Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Apr 15, 2022 9:27am
220 Views
Post# 34606244

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:$tltff The FDA wants an option that has rates better then

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:$tltff The FDA wants an option that has rates better then

Gooseybear wrote: Having received 20 BCG treatments, cancer was reoccurring in the top of my bladder due to BCG not flowing into that area according to my Urologist. This was even after rotating every 15 minutes for two hours. He recommended an inversion machine and was to position to make the BCG available. Currently am NED thank God.

 

Glad to hear you're disease-free.  You make an excellent point.  You can not only have variation in bladder wall architecture across individuals & within a single individual, but certainly the location of the cancer along the bladder wall lining will vary.  It stands to reason, this latter variation can make cancer less accessible  to topical treatments/bladder instillations in some patients.  Depending on cancer location, some patients may simply need to be placed in an appropriate position(s) to allow for optimal treatment/outcomes...simply a matter of physics/geometry.

<< Previous
Bullboard Posts
Next >>